Aprepitant
Thông số
170729-80-3Số CAS
677-636-6Số EC
3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-oneTên IUPAC
C23H21F7N4O3Công thức hóa học
534.4 g/molKhối lượng phân tử
Aprepitant; 170729-80-3; MK-869; MK-0869; Cinvanti; Aponvie; L-754030; ONO-7436; aprepitantum; DTXSID3049047; 1NF15YR6UY; NSC-748825; 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one; L-754,030; CHEBI:499361; DTXCID801021794; 3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-; 5-[[(2R,3S)-2-[(1R)-1-[3,5-BIS(Trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; 3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-4,5-dihydro-1H-1,2,4-triazol-5-one; 3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,4-dihydro-; 3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-4,5-dihydro-1H-1,2,4-triazol-5-one; 3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-; 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-1,2-dihydro-1,2,4-triazol-3-one; RefChem:57104; A04AD12; MK869; 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-3H-1,2,4-Triazol-3-one; MK0517; L754030; L754,030; L 754,030; 677-636-6; Emend; 5-[2(R)-[1(R)-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]-3(S)-(4-FLUOROPHENYL)MORPHOLIN-4-YLMETHYL]-3,4-DIHYDRO-2H-1,2,4-TRIAZOL-3-ONE; MFCD08277635; L 754030; CHEMBL1471; C23H21F7N4O3; 3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one; 321125-94-4; 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-3(2H)-one; Aprepitant [USAN]; 3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one; 5-[(2R,3S)-2-[(R)-1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy]-3-(4-fluoro-phenyl)-morpholin-4-ylmethyl]-2,4-dihydro-[1,2,4]triazol-3-one; 5-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,3-dihydro-1H-1,2,4-triazol-3-one; CAS-170729-80-3; Emend (TN); Aprepitant (MK-0869); MK 869; UNII-1NF15YR6UY; MK 0869; eMende; Aprepitant [USAN:INN:JAN]; Aprepitant`; Aprepitant CRS; NCGC00181785-01; Cinvanti (TN); 5-[[(2R,3S)-2-[(R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-3(2H)-one; aprepitant, form I; Aponvie (TN); aprepitant, form II; MK0869; Aprepitant Impurity I; Aprepitant (Standard); APREPITANT [MI]; APREPITANT [INN]; APREPITANT [JAN]; APREPITANT [VANDF]; APREPITANT [MART.]; APREPITANT [USP-RS]; APREPITANT [WHO-DD]; Aprepitant (JAN/USP/INN); MLS006011068; APREPITANT [EMA EPAR]; SCHEMBL264924; SCHEMBL280611; Aprepitant - Bio-X trade mark; GTPL3490; orb1225953; orb1307556; SCHEMBL7117513; APREPITANT [ORANGE BOOK]; APREPITANT [EP MONOGRAPH]; EX-A212; APREPITANT [USP MONOGRAPH]; GLXC-05008; HMS2090N12; HMS3714E16; HMS3884G05; ONO 7436; Tox21_113595; BDBM50220136; EBC-11285; EBC-27288; HY-10052R; NSC748825; AKOS015895498; AKOS015969344; Tox21_113595_1; CCG-220747; CCG-264854; CS-0487; DB00673; FA17962; NSC 748825; NCGC00181785-03; NCGC00181785-04; NCGC00181785-11; NCGC00181785-12; NCGC00344566-01; 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one; 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one; 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one; AS-14638; BA164216; HY-10052; SMR002530053; SY027654; Aprepitant (MK-0869, L-754030)?; A6368; Aprepitant,MK-0869, L-754030, Emend; C21555; D02968; EN300-761455; SBI-0654102.0001; AB01274775-01; AB01274775_02; AB01275535-01; F862381; SR-05000001531; SR-05000001531-1; BRD-K52827117-001-01-6; Z2937147473; Aprepitant, United States Pharmacopeia (USP) Reference Standard; 3-(((2R,3S)-3-(P-FLUOROPHENYL)-2-(((.ALPHA.R)-.ALPHA.-METHYL-3,5-BIS(TRIFLUOROMETHYL)BENZYL)OXY)MORPHOLINO)METHYL)-.DELTA.(SUP 2)-1,2,4-TRIAZOLIN-5-ONE.; 3-[((2R,5-bis(trifluoromethyl)benzyl]oxy}morpholino)methyl]-.delta.2-1,2,4-triazolin-5-one; 3-[[(2R,3S)-2-[(1R)-1-bis(Trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4dihydro-1,2,4-triazol-5-one; 3-[2-{1-[3,5-di(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)-1,4-oxazinan-4-ylmethyl]-4,5-dihydro-1H-1,2,4-triazol-5-one; 3H-1,2,4-Triazol-3-one, 5-((2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-, (2R-(2alpha(R*),3alpha))-; 3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-, rel-; 3H-1,2,4-Triazol-3-one,5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-,rel-; 3H-1,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-; 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1,2-dihydro-3H-1,2,4-triazol-3-one; 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one; 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-2H-1,2,4-triazol-3(4H)-one; 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol- 3-one; 5-{[(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1,2-dihydro-3H-1,2,4-triazol-3-oneTên gọi khác
Sản phẩm chứa Aprepitant
아탄트캡슐125밀리그램(아프레피탄트)아탄트캡슐80밀리그램(아프레피탄트)에멘드캡슐125밀리그램(아프레피탄트)에멘드캡슐80밀리그램(아프레피탄트)アプレピタントカプセル80mg「NK」/アプレピタントカプセル125mg「NK」/アプレピタントカプセルセット「NK」アプレピタントカプセル125mg「サワイ」/アプレピタントカプセル80mg「サワイ」/アプレピタントカプセルセット「サワイ」EMEND 80 MG CAPSULAS DURASAPREPITANT QILU 80 MG CAPSULAS DURAS EFGAPREPITANT QILU 125 MG CAPSULAS DURAS EFGAPREPITANT QILU 125 MG CAPSULAS DURAS/ APREPITANT QILU 80 MG CAPSULAS DURAS EFGAPREPITANT ACCORD 125 MG CAPSULAS DURAS EFG/APREPITANT ACCORD 80 MG CAPSULAS DURAS EFGEMEND 125 MG POLVO PARA SUSPENSION ORAL
Trang 1/5
Công ty đang bán Aprepitant
SQ
SICHUAN QINGMU PHARMACEUTICAL CO.,LTD.ChinaVP
Viwit Pharmaceutical Co., Ltd.ChinaTE
TIANJIN ENJU BIOTECHNOLOGY CO., LTD.ChinaWP
Wisdom Pharmaceutical Co.,Ltd.ChinaPB
Pure Bio Medical Jiangsu Co.LtdChinaVS
VIATRIS SANTEFranceSF
Sandoz Farmaceutica S.A.SpainSA
SANDOZFranceTrang 1/3